PEOPLE - Boston Scientific makes promotion:
This article was originally published in Clinica
Executive Summary
Roy Anlezark has been promoted to the position of managing director of Boston Scientific, Australia and New Zealand. Mr Anlezark has spent the past three years at the Minneapolis marketing headquarters of Boston, and is the first Australian to be appointed managing director. He will be managing 60 employees in his new role, and further expansion is expected as new products are released.
You may also be interested in...
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.